No events found
We’ll display events we find for MetaVia here
ENTITY
MetaVia (MTVA US)
MetaVia (MTVA US)
7
Analysis
Health Care • United States
MetaVia Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing dual oxyntomodulin (OXM) analog agonist for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). MetaVia serves customers worldwide.
more
x